Cytokine and Chemokine Profiles in Anti-LGI1 Encephalitis

20252 citationsJournal Articlegold Open Access

Authors

Guillermo Muñoz‐Sánchez · Hospital Clínic de Barcelona

Mar Guasp · Centro de Investigación Biomédica en Red

Amaia Muñoz‐Lopetegi · Centro de Investigación Biomédica en Red

Juan Francisco Luchoro · Hospital Clínic de Barcelona

Eugenia Martínez‐Hernández · Hospital Clínic de Barcelona

Laura Naranjo · Hospital Clínic de Barcelona

María Elena Erro

Abstract

In this study, we show that the acute-phase IL-6 CSF/serum ratio and serum IL-35 levels in immunotherapy-naive patients with anti-LGI1 encephalitis are associated with disease severity and poor outcomes, respectively, highlighting their potential as biomarkers for risk stratification and therapeutic targeting.

Topics & Keywords

Autoimmune Neurological Disorders and Treatments Peripheral Neuropathies and Disorders Mast cells and histamine

Publication Details

Published in: Neurology Neuroimmunology & Neuroinflammation

Volume 12, Issue 6, pp. e200492-e200492

DOI: 10.1212/nxi.0000000000200492

Field-Weighted Citation Impact: 2.71

Command Palette

Cytokine and Chemokine Profiles in Anti-LGI1 Encephalitis

Authors

Abstract

Topics & Keywords

Publication Details